Pioneering the Medical Cannabis Industry
BOL Pharma (BOL) has been pioneering the creation of the medical cannabis industry in israel since 2007. The company sources 99% pure pharma grade CBD, THC, and other active ingredients from its own organic GAP certified growing facilities and cGMP certified production plant. Working in conjuction with Israel’s Ministry of Health and under governmental license, BOL serves thousands of patients, doctors, HMOs, and hospitals providing cannabis based medical products and cannabinoid active pharmaceutical ingredients (APIs). As a full service contract manufacturer, BOL produces formulations for clinical research and white label services for the pharmaceuticals, food, supplements, and cosmetics industries.
BOL’s seasoned management team of professionals, medical experts, and researchers bring a wealth of experience and expertise in clinical research, precision agriculture, production and marketing of pharma and health products.
Pharmaceutical Drug Development
BOL Pharma has joined forces with key players to create a unique platform for the development of cannabinoid based drugs. Leveraging Israel’s advanced drug development ecosystem, the company conducts FDA approved clinical trials on its own formulations and offers the same oppotunity to researchers and drug developers. BOL provides cGMP produced APIs, formulations, and sophisticated drug delivery systems as well as a streamlined, highly cost effective process for launching and conducting clinical trials in Israel’s world leading hospitals.
State of the Art Production Facilities
Starting with cutting edge innovation combined with extensive agricultural know-how the company applies precise agro-methodologies enabling complete control of the growth environment. Plants are grown and cultivated in controlled conditions, complying with organic growing protocols and Good Agricultural Practices (GAP). A unique and proprietary combination of monitoring and control methods enables the production of highly consistent botanical based products that deliver optimal medical value.
The company’s end-to-end medical cannabis operation includes handling of finished product, packaging, and climate controlled storage facilites for materials at different stages of production. Based on proprietary patented strains designed to produce specific cannabinoids, plants are cultivated in controlled and automated greenhouses and monitored to ensure harvesting at the peak stage. Post-harvest handling and production is conducted on-site in BOL’s cGMP certified pharma-grade extraction and manufacturing faility.